YARROW BIOSCIENCE, INC. Current Portion of Long-Term Debt
YARROW BIOSCIENCE, INC. (YARW) had Current Portion of Long-Term Debt of $0 as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LongTermDebtCurrent · last filed 2021-11-10
- 2021-09-30: Long-term Debt, Current Maturities $0.00.
- 2021-06-30: Long-term Debt, Current Maturities $33.38M.
- 2020-12-31: Long-term Debt, Current Maturities $0.00.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $33.38M 10-Q · filed 2021-08-12 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |